Navigation Links
Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference
Date:10/24/2007

Updated phase 2 data continue to show encouraging anti-tumor activity in non- small cell lung cancer; Phase 1 data demonstrate tolerability of daily

XL647 administration

SAN FRANCISCO, Oct. 24 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) today reported updated data from a phase 2 study of XL647, an inhibitor of EGFR, HER2 and VEGFR kinases, in previously untreated, clinically selected non-small cell lung cancer (NSCLC) patients. The data continue to show encouraging anti-tumor activity for XL647 administered on an intermittent schedule. Additionally, XL647 was generally well tolerated and showed pharmacodynamic target modulation in an ongoing phase 1 study evaluating daily dosing in patients with advanced solid tumors. The data were presented in two posters at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held October 22-26, 2007 in San Francisco.

Consistent with data from the phase 2 study reported in September 2007 at the 12th International Association for the Study of Lung Cancer World Conference on Lung Cancer, 68% of the 34 patients evaluable for tumor response had clinical benefit: 10 patients had partial responses (eight confirmed, two not yet confirmed), and 13 patients had stable disease as their best response. All seven patients with activating EGFR mutations experienced tumor shrinkage (six PRs and one SD), and three patients with wild type EGFR achieved partial responses (Abstract #B124). XL647 was generally well tolerated in this patient population.

Additionally, data from a phase 1 dose-escalation study evaluating daily dosing of XL647 were presented (Abstract #B242). As of August 8, 2007,
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Six Abstracts Featuring Exelixis Compounds Accepted At ASCO Conference
2. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
3. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
4. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
5. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
6. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
7. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
10. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
11. CytRx Reports Promising Data from Its Open-Label Extension Clinical Trial of Arimoclomol in ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Research and Markets  has announced the addition of ... report to their offering. The Global ... in-depth study on the current state of the global ... basic overview of the industry including definitions, classifications, applications ... is provided for the international markets including development trends, ...
(Date:8/27/2014)... Aug. 27, 2014 Decision Resources Group finds ... Memphis health system and hospital ... integration, with rivals Methodist Le Bonheur Healthcare and Baptist ... to coordinate patient care. In addition, a national contract ... most health plan enrollment in the Memphis ...
(Date:8/27/2014)... , August 27, 2014 ResearchMoz ... States  Laparoscopes Market Outlook to 2020. New report, ... market data on the United States Laparoscopes market ... dollars, volume (in units) and average prices (in US ... Laparoscopes and Flexible Tip Video Laparoscopes), Robotic Surgical Systems ...
Breaking Medicine Technology:Global Pulse Oximeter Industry Report 2014 2Memphis-area Health Systems Turn Attention to Clinical Integration 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... Saturday, August 20, veterinary cardiologists are going to the ... Heart Health Tour will stop with a soundproof medical ... Dog Park. (Photo:   http://photos.prnewswire.com/prnh/20110815/CG52446 ) ... veterinarians will be available to answer questions for dog ...
... 2011 For the first time, the U.S. ... clarifying how benefit-risk determinations are made during premarket ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Released today, the ... regulatory pathway for high-risk medical devices. The recommendations ...
Cached Medicine Technology:Free Dog Heart Health Screenings Available August 20 in Providence 2FDA Proposes Guidelines That Clarify Benefit-Risk Determinations for Medical Devices 2
(Date:8/27/2014)... report provides market analysis of “Military Laser Systems Market ... scanner, Laser Weapon, Dazzlers, Laser sights, Proximity Fuze, Ring ... (Aerospace, Defense and Homeland Security) - Forecast and Analysis ... application in the aerospace and defense market over next ... expected to register a CAGR of 4.23% to reach ...
(Date:8/27/2014)... BambooIndustry.com, an innovative company that provides many kinds of top ... are now offered on its website. In addition, the ... people that place an order for its newly released items ... off. , The company’s senior spokesman was excited to ... new and old customers can buy cheap bamboo panels on ...
(Date:8/27/2014)... DC (PRWEB) August 28, 2014 The ... Betty Pierce Dennis, DrPH, MN, RN, FAAN, became the ... Center for the Advancement of the Science of Nursing ... of seven that comprise the NLN Home for Transformative ... nation’s capital a year ago. , Under Dr. ...
(Date:8/27/2014)... For those who want to build ... products are very practical. Top10BestSEOHosting.com today announces that ... the best ASP.NET hosting suppliers of this year. ... top web hosting provider for a long time, ... today. Recently proclaimed one of the fastest growing ...
(Date:8/27/2014)... Broken Arrow, OK (PRWEB) August 27, 2014 ... provide their guests a comfortable bed to sleep without breaking ... in the market for a new foam mattress set for ... guests to sleep on, Bedding Mart has it all during ... , stock up on some of the best mattresses for ...
Breaking Medicine News(10 mins):Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Military Laser Systems Market Worth $2.73 Billion by 2020 - New Report by MarketsandMarkets 4Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 2Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 3Health News:Betty Pierce Dennis to Lead NLN/Chamberlain College of Nursing Center for the Advancement of the Science of Nursing Education 4Health News:Top10BestSEOHosting.com Releases the Best ASP.NET Hosting Suppliers of This Year: Hostgator, Arvixe and FatCow 2Health News:Bedding Mart, Top Mattress Store in Broken Arrow Oklahoma, Announces a Huge Labor Day Sale 2
... OWINGS MILLS, Md., July 23 Medifast, Inc. (NYSE: ... financial results for the period ended June 30, 2009 on Thursday, July 30, ... conference call and web cast to discuss the results on Thursday, July 30, ... parties can access the call by dialing (877) 407-0782 or (201) 689-8567, or ...
... July 23 /PRNewswire-FirstCall/ - AlphaRx, Inc. (OTCBB: ALRX) ... inhaled tobramycin nanoparticle (Zysolin(TM)) formulation was a more ... aeruginosa pneumonia when compared to inhaled and injected ... in an oral podium session at the 36th ...
... , , CHARLOTTE, N.C., July 23 MedCath Corporation (Nasdaq: ... to discuss results from its third quarter ended June 30, 2009. The company will issue a ... What: Third Quarter Earnings Conference ... 2009, How: Dial-in conference call, ...
... , , , ... reported results for the 2009 second quarter and first half ended June 30, ... second quarter and decreased 5% to $11.1 billion for the 2009 first half. ... for the 2009 second quarter and first half. , ...
... , , , ... DRAD ), today reported that stronger revenue from its Product (nuclear ... $784,000 in net profits and more than $3 million in positive cash ... , , Digirad CEO Todd Clyde said, ...
... ... eMindful is launching live, interactive yoga classes. As a special promotion eMindful is offering ... opportunity for anyone who has a yoga practice, or has wanted to explore the health ... ...
Cached Medicine News:Health News:Medifast, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday, July 30, 2009 2Health News:AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting 2Health News:AlphaRx Presents Positive Preclinical Data on Zysolin(TM) Inhalable Nanoparticles at Controlled Release Society Annual Meeting 3Health News:MedCath Corporation to Hold Conference Call on Third Quarter Results 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 2Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 3Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 4Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 5Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 6Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 7Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 8Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 9Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 10Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 11Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 12Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 13Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 14Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 15Health News:Wyeth Reports Earnings Results for the 2009 Second Quarter and First Half and Raises Full Year 2009 Guidance 16Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 2Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 3Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 4Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 5Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 6Health News:Digirad Corporation Reports Second Quarter 2009 Financial Results 7Health News:eMindful.com Launches Live, Interactive Online Yoga Classes 2Health News:eMindful.com Launches Live, Interactive Online Yoga Classes 3
For the quantitative determination of aspartate aminotransferase (AST) in human serum. The reagents are used in routine examination and monitoring of therapy and relapses....
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 440 U/L at 30C. Liquid buffer and dry powder r...
The Midas II Stainer is an automated slide stainer designed for use in hematology and microbiology laboratories....
... 44 is an "assembly-line worker" for routine ... cytology laboratories. It automatically stains big quantities ... increased large number of reagent stations in ... a high throughput. Up to 12 baskets ...
Medicine Products: